Is CME stock a Buy, Sell, or Hold?

Based on our analysis, CME is currently a WAIT with low confidence. 📊 MIXED SIGNALS: CME shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of CME stock?

Our analysis estimates the fair value range for CME to be between $243.31 and $265.00. The current price is $269.80.

What is the analyst price target for CME?

The average Wall Street analyst price target for CME is $284.13. This implies a potential upside of 5.3% from current levels.

CME Stock Analysis: Buy, Sell, or Hold?

CME - CME Group Inc.

SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES

$269.80

2.59 (0.97%) ▲

5d: +2.33%

30d: +9.55%

90d: -9.37%

WAIT

LOW Confidence

Protect Your CME Gains

Analysis Updated: Aug 14, 2026 12:00 AM ET

Earnings: Oct 21, 2026

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Aug 7, 2026 at $263.66 · last confirmed Aug 14, 2026

Strength: 6.5/10

Get Alerted When CME Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: CME shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 5.4%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$362.88

Based on 4.7% avg growth

INTRINSIC VALUE TODAY

$225.32

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.3x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: CME is currently trading at $269.80, which is considered extended relative to its 30-day fair value range of $243.31 to $265.00. The stock's valuation (Forward PE: 20.9) is in line with its historical norms (22.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.2% over the next few years. This pessimistic expectation contrasts with the company's recent 2.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, CME is in a strong downtrend. The price is approaching resistance at $271.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $243.31 - $265.00

Company Quality Score 42/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 46.2%

Protect Your Profits

Holding CME? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
NEUTRAL: Mixed technical signals (50/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($284.13)
WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $243.31 - $265.00

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $256.83

Resistance Level $271.09

Current Trend Strong Downtrend

Technical data as of Aug 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 20.86

Wall Street Target $284.13 (+5.3%)

Revenue Growth (YoY) 0.8%

Earnings Growth (YoY) 2.5%

Profit Margin 63.4%

Valuation Discount vs History -2.2% cheaper

PE vs Historical 20.9 vs 22.3 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -2.2% (market-implied from PE analysis)

1-Year Target $263.86 (-2%)

2-Year Target $258.06 (-4%)

3-Year Target $252.38 (-7%)

3-Yr Target (if PE normalizes) (PE: 21→22) $269.82 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.9, Growth: 5.4%) $316.26 (+17%)

Base: (SPY PE: 20.2, Growth: 5.4%) $306.72 (+14%)

Bear: (PE: 17.2, Growth: 5.4%) $260.71 (-3%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (21x PE) as earnings recover.

Trailing PE: 22.23 | Current EPS (TTM): $12.02

Bull Case $316.29 (+17%)

Analyst growth 7.6%, PE expands to 24.5

Base Case $287.54 (+7%)

Market implied 7.6%, PE stable at 22.2

Bear Case $181.70 (-33%)

Severe decline -20.0%, PE contracts to 18.9

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 20.9 to 22.3

Stabilization Target: $288.44 (+6.9%)

PE Expansion Potential: +6.9%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: August 15, 2026 10:32 AM ET
Data refreshes hourly during market hours. Next update: 11:32 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is CME showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Jonathan L Marcus SELL 3291 shares 2026-03-17

Bryan T Durkin SELL 4200 shares 2026-02-23

Martin J Gepsman SELL 300 shares 2026-02-20

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for CME.

Create Free Account

Already have an account? Log In

Top Rated Financial Data & Stock Exchanges Stocks

Top-rated stocks in Financial Data & Stock Exchanges by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
SPGI S&P Global Inc	STRONG BUY 26 analysts	$517	68 BUY
COIN Coinbase Global Inc	HOLD 29 analysts	$196	63 BUY
MCO Moodys Corporation	BUY 23 analysts	$560	65 BUY
MSCI MSCI Inc	BUY 19 analysts	$692	68 BUY
TRU TransUnion	STRONG BUY 20 analysts	$96	49 HOLD

SPGI S&P Global Inc

68 BUY

COIN Coinbase Global I…

63 BUY

MCO Moodys Corporation

Advanced CME Option Strategies

Professional options setups generated by AI based on today's CME price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CME

CME Technical Chart CME Price Prediction CME Earnings Date CME Investment Advisor CME Fair Price Analyzer CME Options Advisor CME Options Chain CME Options Analysis CME Competitors

Compare CME with Peers

CME vs ICE
Which one to buy?

CME vs CBOE
Which one to buy?

CME vs NDAQ
Which one to buy?

CME vs SPGI
Which one to buy?

CME vs MCO
Which one to buy?

SPGI vs CME
Winner: CME

BGC vs CME
Winner: CME

Create New Comparison View All Competitors

Tradestie